The Institute for Clinical and Economic Review (ICER) is an innovative, independent non-profit health care research organization dedicated to improving the application of evidence throughout the health care system. ICER produces influential public reports evaluating the clinical effectiveness and value of new treatments, tests, and delivery system interventions. These reports have strongly influenced insurance coverage policies and clinical guidelines while gaining prominence within the national debate over the cost of health care. ICER thrives on the entrepreneurial spirit of its employees to empower patients, clinicians, and policymakers in their quest for better care at lower costs. In everything we do, our organization seeks to foster an honest public dialogue about the evidence on effectiveness and value, and to translate this evidence into action to improve patient care.
ICER is looking to expand its team, which includes a diverse set of clinicians, researchers, and policy experts. We are seeking a Senior Health Economistto help lead the health technology assessment and economic evaluation activities that serve as the backbone for all of our work. Details on the specific responsibilities and minimum qualifications are provided below.
Job Summary Reporting to the Chief Scientific Officer of ICER, the position requires a senior and accomplished individual of exceptional caliber. The ideal candidate has doctorate-level training in health economics, decision sciences, or operations research and a compelling personal record of work in the fields of health technology assessment, comparative effectiveness research, and/or health services research. Given the leadership role envisioned for this position, it requires a person of unquestionable integrity, with exceptional communication and presentation skills, and an ability to engage with and influence a broad range of stakeholders.
The Senior Health Economist will be responsible for supporting the development and refinement of ICER’s methods for the conduct and presentation of evaluations of the cost effectiveness, cost-benefit, and budgetary impact of drugs, devices, health-system interventions, and other technologies. The successful candidate will also work with ICER’s Director of Health Economics and Senior Management Team to refine relevant components of ICER’s public processes, such as the use of data submitted “in-confidence” by stakeholders as well as the organization’s policies regarding transparency in its modeling efforts. This individual will also represent ICER at a variety of external academic and policy venues, and will be expected to generate white papers and academic publications to support ICER’s methods. Finally, the Senior Health Economist will be expected to participate in the authorship of technical briefs to support the organization’s annual Policy Summit.
The Senior Health Economist will also consult with internal project teams and external health economic collaborators on specific ICER reports; based on specific experience, direct management of health economists and research assistants is an option. Areas of responsibility will include conception and design of health-economic models, consulting with manufacturers and other stakeholders on the type and format for submitted data as deemed useful for modeling purposes, organizing and deploying resources to fully vet assumptions, parameters, functions, and operations to ensure the robustness of both externally- and internally-developed models, and assisting with ICER’s response to informal and formal comment on model structure and findings.
It is not intended that the above listed duties reflect every job duty, responsibility or task that the employee may be called upon to perform. The employee is expected to perform all job-related duties and tasks assigned by his/her supervising manager or other authorized manager. Interested candidates should e-mail resume and cover letter; please also include contact information should we wish to schedule an interview.
Minimum Educational Requirements
Generally, a doctoral degree is preferred in a relevant discipline such as decision sciences, health economics, operations research, biostatistics, epidemiology or a related quantitative social science field. Exceptions may be made for Master’s degree candidates with experience developing health?focused econometric models using decision analysis software.
Three or more years of experience (5 or more years to be considered a candidate for the Senior position) in conducting health technology assessments, academic health-economic modeling, or similar work requiring development, specification, and testing of modeling methods. Candidates must be outstanding writers, able to write clearly and cogently without requiring editorial assistance, and must be facile editors of the drafts of others. The scope of writing will include a wide range of material, including different versions of technical evidence reports and health policy briefs. Candidates must be able to demonstrate substantial experience in the critical evaluation of evidence, including the ability to critique the research methods and statistical findings of published economic studies to put the development of the current model in the appropriate context. Finally, qualified candidates will be accomplished presenters with experience in conveying complex econometric methods to a variety of audiences.
A strong track record of mentorship of research staff.
Analytical, consulting and project management experience, including demonstrated ability to determine the key areas of controversy in a clinical area, to conceptualize the appropriate project scope, and to develop appropriate action plans from multidisciplinary perspectives.
The highest levels of personal initiative, attention to detail, and independent work.
Efficiency, collaboration, candor, openness, results orientation and a commitment to a consultative approach to decision-making.
About Institute for Clinical and Economic Review
The Institute for Clinical and Economic Review (ICER) is an independent non-profit research institute
that produces reports analyzing the evidence on the effectiveness and value of drugs and other medical
services. ICER’s reports include evidence-based calculations of prices for new drugs that accurately
reflect the degree of improvement expected in long-term patient outcomes, while also highlighting price
levels that might contribute to unaffordable short-term cost growth for the overall health care system.
ICER’s reports incorporate extensive input from all stakeholders and are the subject of public hearings
through three core programs: the California Technology Assessment Forum (CTAF), the Midwest
Comparative Effectiveness Public Advisory Council (Midwest CEPAC), and the New England Comparative
Effectiveness Public Advisory Council (New England CEPAC). These independent panels review ICER’s
reports at public meetings to deliberate on the evidence and develop recommendations for how
patients, clinicians, insurers, and policymakers can improve the quality and value of health care.
Through all its work, ICER seeks to play a pivotal role in creating a future in which coll...aborative efforts to
move evidence into action provide a foundation for a more effective, efficient, and just health care
system. For more information about ICER, please visit ICER’s website.